GlassScriptPhysician profile
Jennifer S Beaty
NPI 1427094648
$390.12
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $390.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $136.61 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.43 | 2019 | |
| Mallinckrodt Enterprises LLC | $68.67 | 2019 | |
| Covidien LP | $26.28 | 2019 | |
| Medtronic USA, INC. | $18.55 | 2019 | |
| Cook Medical LLC | $18.43 | 2019 | |
| Boston Scientific Corporation | $12.18 | 2019 | |
| Palette Life Sciences, INC. | $11.97 | 2019 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Beaty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.